Write in a clean editor, then format for Frontiers in Tuberculosis in one click — DocuGuru applies the official Frontiers template with numbered references and exports a submission-ready PDF plus the editable LaTeX source. Free to start.
Frontiers in Tuberculosis is a peer-reviewed journal published by Frontiers, covering Tuberculosis Research and Epidemiology, Mycobacterium research and diagnosis, Diagnosis and treatment of tuberculosis. Over its lifetime it has published 72 papers, which have received 130 citations.
| Publisher | Frontiers |
|---|---|
| Reference style | Numbered (Vancouver) Numbered — [1], [2] in the text 1. Smith A, Jones B, Lee C. A representative article title. Frontiers in Tuberculosis. 2023;12(3):45–58.
Formats any DOI in Frontiers in Tuberculosis style. No sign-up. |
| Publishes research in | Tuberculosis Research and Epidemiology Mycobacterium research and diagnosis Diagnosis and treatment of tuberculosis Pneumonia and Respiratory Infections Infectious Diseases and Tuberculosis |
| ISSN | 2813-7868 |
| Citation impact (2-yr) | 1.71 |
| h-index | 5 |
| i10-index | 3 |
| Open access | Yes — indexed in DOAJ |
| Top institutions publishing here | Rutgers, The State University of New Jersey |
| You get | A submission-ready PDF and the editable LaTeX source — ready to submit. |
Citations each year’s papers have accumulated so far — the most recent years are still building up.
Despite impacting mankind since ancient times, tuberculosis (TB) persists as the leading cause of death from an infectious disease. TB can remain latent and further research is required to understand activation risk and the risks vs. the benefits of treating latent infection. Drug resistance poses an escalating threat to treating active disease and achieving cure.…
The laboratory plays a vital role in the diagnosis of all clinical forms of tuberculosis (TB), from microbiological confirmation of Mycobacterium tuberculosis to drug-susceptibility testing (DST) and treatment monitoring. For many decades, laboratory diagnosis of tuberculosis was based on conventional methods such as smear microscopy, and culture-based methods. However, Mycobacterium tuberculosis is a slow-growing organism,…
Despite advancements in modern medicine, tuberculosis continues to be one of the leading causes of death globally. Findings indicate that COVID-19 may trigger the activation of tuberculosis infection (TB), leading to its spread. Despite the development of new immunological diagnostic methods for latent tuberculosis infection (LTBI), it is still unclear how the infection transitions to…
Introduction Chronic pulmonary infection with Mycobacterium abscessus ( M. abscessus ) is a significant cause of morbidity and mortality in people with cystic fibrosis (CF). Developing an animal model of M. abscessus pulmonary infection, especially under CF conditions, is essential to understanding clinical pulmonary M. abscessus infection. βENaC transgenic mice are known to develop spontaneous…
Mycobacterium tuberculosis ( Mtb ) is the causative agent of tuberculosis (TB) in humans, Although Mtb is primarily considered a respiratory pathogen, its ability to spread to and affect the central nervous system (CNS) is of particular interest due to its clinical importance. Tuberculosis meningitis (TBM) is described as the manifestation of Mtb infection in…
